ChitogenX Inc.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regene… Read more
ChitogenX Inc. (CHNXF) - Total Liabilities
Latest total liabilities as of October 2024: $7.75 Million USD
Based on the latest financial reports, ChitogenX Inc. (CHNXF) has total liabilities worth $7.75 Million USD as of October 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ChitogenX Inc. - Total Liabilities Trend (2019–2024)
This chart illustrates how ChitogenX Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ChitogenX Inc. Competitors by Total Liabilities
The table below lists competitors of ChitogenX Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Stark Focus Group Inc
PINK:SKFG
|
USA | $172.16K |
|
United Corporations Limited
TO:UNC
|
Canada | CA$122.62 Million |
|
VNET Group Inc
STU:217A
|
Germany | €22.57 Billion |
|
Vivanco Gruppe AG
F:VG0K
|
Germany | €23.05 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down ChitogenX Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 20.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ChitogenX Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ChitogenX Inc. (2019–2024)
The table below shows the annual total liabilities of ChitogenX Inc. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-01-31 | $6.71 Million | -36.57% |
| 2023-01-31 | $10.58 Million | +28.61% |
| 2022-01-31 | $8.23 Million | +62.01% |
| 2021-01-31 | $5.08 Million | +37.76% |
| 2020-01-31 | $3.69 Million | +68.09% |
| 2019-01-31 | $2.19 Million | -- |